SS18 and synovial sarcoma: KDM2B is a histone demethylase and component of a non-canonical polycomb repressive complex 1 (PRC1.1), that has been reported by Banito et al. to function as a mediator for the oncogenic activity of SS18::SSX1, contributing to synovial sarcomagenesis and the SS signature.